Skip to main content

Articles

Page 206 of 209

  1. A commonly reported problem with the conduct of multicentre randomised controlled trials (RCTs) is that recruitment is often slower or more difficult than expected, with many trials failing to reach their plan...

    Authors: Alison M McDonald, Rosemary C Knight, Marion K Campbell, Vikki A Entwistle, Adrian M Grant, Jonathan A Cook, Diana R Elbourne, David Francis, Jo Garcia, Ian Roberts and Claire Snowdon
    Citation: Trials 2006 7:9
  2. Patients with chronic kidney disease (CKD) are at a greatly increased risk of developing cardiovascular disease. Recently developed guidelines address multiple risk factors and life-style interventions. Howeve...

    Authors: Arjan D van Zuilen, Ingeborgh van der Tweel, Peter J Blankestijn, Michiel L Bots, Marjolijn van Buren, Marc AGJ ten Dam, Karin AH Kaasjager, Peter JG van de Ven, Gerald Vervoort, Louis-Jean Vleming, Gerry Ligtenberg and Jack FM Wetzels
    Citation: Trials 2006 7:8
  3. Standard coronary artery bypass graft surgery uses a single internal mammary artery and supplemental vein or radial artery grafts. Several observational studies have suggested a survival benefit with two inter...

    Authors: David P Taggart, Belinda Lees, Alastair Gray, Douglas G Altman, Marcus Flather and Keith Channon
    Citation: Trials 2006 7:7
  4. This editorial introduces the new online, open access, peer-reviewed journal Trials. The journal considers manuscripts on any aspect of the design, performance, and findings of randomised controlled trials in any...

    Authors: Douglas G Altman, Curt D Furberg, Jeremy M Grimshaw and Peter M Rothwell
    Citation: Trials 2006 7:6
  5. Falls in older people are a major public health concern in terms of morbidity, mortality and cost. Previous studies suggest that multifactorial interventions can reduce falls, and many geriatric day hospitals ...

    Authors: Tahir Masud, Carol Coupland, Avril Drummond, John Gladman, Denise Kendrick, Tracey Sach, Rowan Harwood, Pradeep Kumar, Rob Morris, Rachael Taylor, Jane Youde and Simon Conroy
    Citation: Trials 2006 7:5
  6. The shoulder is the most frequently dislocated joint in the body. Multiple causes and pathologies account for the various types of shoulder instability. Multi-directional instability (MDI) and multi-directiona...

    Authors: NG Mohtadi, RM Hollinshead, PJ Ceponis, DS Chan and GH Fick
    Citation: Trials 2006 7:4
  7. We have previously described how a series of trials sponsored by Pfizer of its antifungal drug, fluconazole, in cancer patients with neutropenia handicapped the control drug, amphotericin B, by flaws in design...

    Authors: Karsten J Jørgensen, Helle Krogh Johansen and Peter C Gøtzsche
    Citation: Trials 2006 7:3
  8. The purpose of this study is to compare the efficacy of prophylactic antibiotic for prevention of meningitis in acute traumatic pneumocephalus patients.

    Authors: Behzad Eftekhar, Mohammad Ghodsi, Azar Hadadi, Mousa Taghipoor, Samira Zabihyan Sigarchi, Vafa Rahimi-Movaghar, Ehsan Sherafat Kazemzadeh, Babak Esmaeeli, Farideh Nejat, Alireza Yalda and Ebrahim Ketabchi
    Citation: Trials 2006 7:2
  9. Stent length serves as a predictor of restenosis in use of bare metal stents (BMS). This has been demonstrated in a feasibility study that used a single short BMS implant (<9 mm) in a high proportion of lesion...

    Authors: Ulrich Dietz, Cheryl Dauer and Heinz Lambertz
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:18
  10. Cobalt chromium coronary stents are increasingly being used in percutaneous coronary interventions. There are, however, no reliable data about the characteristics of unfolding and visibility of this stent alloy i...

    Authors: Jens Hagemeister, Frank M Baer, Robert HG Schwinger and Hans W Höpp
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:17
  11. Pharmacogenetic testing to individualize ACE inhibitor therapy remains controversial. We conducted a systematic review to assess the effect modification of the insertion/deletion (I/D) polymorphism of the ACE ...

    Authors: Madlaina Scharplatz, Milo A Puhan, Johann Steurer, Annalisa Perna and Lucas M Bachmann
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:16
  12. Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery. The process of saphenous vein intimal hyperplasia begins just days after surgical revascularization, setting the...

    Authors: Alexander Kulik, Michel Le May, George A Wells, Thierry G Mesana and Marc Ruel
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:15
  13. The aim of this prospective study of patients undergoing repair of non-ruptured abdominal aortic aneurysm between 1999 and 2003 was to evaluate and compare risk factors for mortality after surgery, to determin...

    Authors: Sigitas Urbonavicius, Henrik Vorum, Grazina Urbonaviciene, Mindaugas Trumpickas, Dainius Pavalkis and Bent Honoré
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:14
  14. In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and mor...

    Authors: Alper Sami Kunt, Osman Tansel Darcın and Mehmet Halit Andac
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:13
  15. Cardiac biomarkers are routinely obtained in the setting of suspected myocardial ischemia and infarction. Evidence suggests these markers may correlate with functional and clinical outcomes, but the strength o...

    Authors: Aslan T Turer, Kenneth W Mahaffey, Dianne Gallup, W Douglas Weaver, Robert H Christenson, Nathan R Every and E Magnus Ohman
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:12
  16. The aim of the SPHERE study is to design, implement and evaluate tailored practice and personal care plans to improve the process of care and objective clinical outcomes for patients with established coronary ...

    Authors: Andrew W Murphy, Margaret E Cupples, Susan M Smith, Molly Byrne, Claire Leathem and Mary C Byrne
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:11
  17. Female cardiac transplant recipients' aerobic capacity is 60% lower than sex and age-predicted values. The effect of exercise training on restoring the impaired aerobic endurance and muscle strength in female ...

    Authors: Mark Haykowsky, Kenneth Riess, Linda Figgures, Daniel Kim, Darren Warburton, Lee Jones and Wayne Tymchak
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:10
  18. Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased risk of cardiovascular ...

    Authors: Bengt Fellström, Faiez Zannad, Roland Schmieder, Hallvard Holdaas, Alan Jardine, Helen Rose and Wim Wilpshaar
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:9
  19. The high incidence of cardiovascular disease in patients with end stage renal disease (ESRD) is related to the accumulation of uremic toxins in the middle and large-middle molecular weight range. As online hem...

    Authors: E Lars Penne, Peter J Blankestijn, Michiel L Bots, Marinus A van den Dorpel, Muriel P Grooteman, Menso J Nubé, Ingeborg van der Tweel and Piet M ter Wee
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:8
  20. Spinal cord electrical stimulation (SCS) has shown to be a treatment option for patients suffering from angina pectoris CCS III-IV although being on optimal medication and not suitable for conventional treatme...

    Authors: Holger Diedrichs, Carsten Zobel, Peter Theissen, Michael Weber, Athanassios Koulousakis, Harald Schicha and Robert HG Schwinger
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:7
  21. Despite widespread availability of a large body of evidence in the area of hypertension, the translation of that evidence into viable recommendations aimed at improving the quality of health care is very diffi...

    Authors: Cornel Pater
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:6
  22. Activation of inflammatory pathways plays an important contributory role in coronary plaque instability and subsequent rupture, which can lead to the development of acute coronary syndrome (ACS). Elevated leve...

    Authors: Petr Ostadal, David Alan, Petr Hajek, Jiri Vejvoda, Martin Mates, Peter Blasko, Josef Veselka, Milan Kvapil, Jiri Kettner, Martin Wiendl, Ondrej Aschermann, Josef Slaby, Eduard Nemecek, Frantisek Holm, Marek Rac, Milan Macek…
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:4
  23. Surrogate measures for cardiovascular disease events have the potential to increase greatly the efficiency of clinical trials. A leading candidate for such a surrogate is the progression of intima-media thickn...

    Authors: Mark A Espeland, Daniel H O'Leary, James G Terry, Timothy Morgan, Greg Evans and Harald Mudra
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:3
  24. Although the association between mitral stenosis (MS) and increased coagulation activity is well recognized, it is unclear whether enhanced coagulation remains localized in the left atrium or whether this repr...

    Authors: Istemihan Tengiz, Ertugrul Ercan, Fahri Sahin, Emin Alioglu, Can Duman, Guray Saydam and Filiz Buyukkececi
    Citation: Current Controlled Trials in Cardiovascular Medicine 2005 6:2
  25. The delivery of implantable cardioverter defibrillator (ICD) therapy is sophisticated and requires the programming of over 100 settings. Physicians tailor these settings with the intention of optimizing ICD th...

    Authors: John M Morgan, Laurence D Sterns, Jodi L Hanson, Kevin T Ousdigian, Mary F Otterness and Bruce L Wilkoff
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:12
  26. Although percutaneous coronary intervention (PCI) is becoming the standard therapy in ST-segment elevation myocardial infarction (STEMI), to date most patients, even in developed countries, are reperfused with...

    Authors: Ramon B van Loon, Gerrit Veen, Otto Kamp, Jean GF Bronzwaer, Cees A Visser and Frans C Visser
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:11
  27. Matrix metalloproteinases (MMPs) have been implicated in the pathogenesis of arterial aneurysms through increased proteolysis of extracellular matrix proteins. Increased proteolysis due to elevated matrix degr...

    Authors: Istemihan Tengiz, Ertugrul Ercan, Emil Aliyev, Cevad Sekuri, Can Duman and Imre Altuglu
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:10
  28. Hypertension and diabetes mellitus are closely interrelated and coexist in as many as two-thirds of patients with type 2 diabetes. The consequent risk of such an association is an accelerated development of at...

    Authors: Cornel Pater, Deepak Bhatnagar, Jean-Pascal Berrou, Joachim Luszick and Katrin Beckmann
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:9
  29. A large number of randomized clinical trials with important health outcomes are completed each year. Those with favorable findings are typically reported and published rapidly, while the publication of those w...

    Authors: Curt D Furberg, Mark A Hall and Mary Ann Sevick
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:6
  30. Noncompliance with study medications is an important issue in the design of endpoint clinical trials. Including noncompliant patient data in an intention-to-treat analysis could seriously decrease study power....

    Authors: Steven M Snapinn, Qi Jiang and Boris Iglewicz
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:5
  31. The existence of effective therapies for most cardiovascular disease states, coupled with increased requirements that potential benefits of new drugs be evaluated on clinical rather than surrogate endpoints, m...

    Authors: Cornel Pater
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:4
  32. Ximelagatran is a novel oral direct thrombin inhibitor. It has favorable pharmacodynamic properties, with a broad therapeutic range without the need for anticoagulation monitoring. We aimed to discover whether...

    Authors: Christopher J Boos and Ranjit S More
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:3
  33. Trials in the 1990s demonstrated that medical therapy is as effective as invasive therapies for treating single-vessel coronary disease. Yet more recent studies enrolling patients with this condition have focu...

    Authors: Samer Jabbour, Shmuel Ravid and Bernard Lown
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:2
  34. In order to avoid the complications associated with thromboembolic disease, patients with this condition typically are placed on long-term anticoagulant therapy. This report compares bleeding complications in ...

    Authors: Ufuk Yetkin, Özalp Karabay and Hakan Önol
    Citation: Current Controlled Trials in Cardiovascular Medicine 2004 5:1
  35. A large body of data derived from animal, epidemiological and clinical studies indicate that n-3 polyunsaturated fatty acids have a favourable effect on the prognosis of patients with cardiovascular disease in...

    Authors: Cornel Pater, Daniele Compagnone, Joachim Luszick and Cees-Nico Verboom
    Citation: Current Controlled Trials in Cardiovascular Medicine 2003 4:2
  36. Currently, there are a lack of investigations that have examined the effect of participating in a comprehensive cardiac rehabilitation program on quality of life and physiological measures in women of differen...

    Authors: Michael D Kennedy, Mark Haykowsky, Bill Daub, Karen van Lohuizen, Grant Knapik and Bill Black
    Citation: Current Controlled Trials in Cardiovascular Medicine 2003 4:1
  37. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, double-blind, active-controlled trial designed to compare the rate of coronary heart disease events in ...

    Authors: Linda B Piller, Barry R Davis, Jeffrey A Cutler, William C Cushman, Jackson T Wright Jr, Jeff D Williamson, Frans HH Leenen, Paula T Einhorn, Otelio S Randall, John S Golden and L Julian Haywood
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:10
  38. Cardiac rehabilitation programs (CRP) represent comprehensive interventions that are typically limited to four months. Following completion of CRP, it appears that risk factors and lifestyle behaviours may det...

    Authors: Scott A Lear, Andrew Ignaszewski, Wolfgang Linden, Anka Brozic, Marla Kiess, John J Spinelli, P Haydn Pritchard and Jiri J Frohlich
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:9
  39. PROSPER was designed to investigate the benefits of treatment with pravastatin in elderly patients for whom a typical doctor might consider the prescription of statin therapy to be a realistic option.

    Authors: Ian Ford, Gerard Jan Blauw, Michael B Murphy, James Shepherd, Stuart M Cobbe, Edward LEM Bollen, Brendan M Buckley, J Wouter Jukema, Michael Hyland, Allan Gaw, A Margot Lagaay, Ivan J Perry, Peter Macfarlane, John Norrie, A Edo Meinders, Brian J Sweeney…
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:8
  40. The "integrated safety report" of the drug registration files submitted to health authorities usually summarizes the rates of adverse events observed for a new drug, placebo or active control drugs by pooling ...

    Authors: Michel Lièvre, Michel Cucherat and Alain Leizorovicz
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:6
  41. Antioxidant supplementation with vitamin E had no effect in the prevention of cardiovascular diseases (CVD) in three recent large, randomized clinical trials. In order to reassess critically the role of vitami...

    Authors: Chiara Chiabrando, Fausto Avanzini, Claudia Rivalta, Fabio Colombo, Roberto Fanelli, Gaetana Palumbo and Maria Carla Roncaglioni
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:5
  42. Although diabetes mellitus is predominantly a metabolic disorder, recent data suggest that it is as much a vascular disorder. Cardiovascular complications are the leading cause of death and disability in patie...

    Authors: Prakash C Deedwania
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:2
  43. Overweight older adults are often counseled to lose weight, even though there is little evidence of excess mortality in that age group. Overweight and underweight may be more associated with health status than...

    Authors: Paula Diehr, Anne B Newman, Sharon A Jackson, Lewis Kuller and Neil Powe
    Citation: Current Controlled Trials in Cardiovascular Medicine 2002 3:1

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    6,282,238 downloads
    5,569 Altmetric mentions